Sonja Nakasian

Epiveris

BIOGRAPHY

Sonja Nakasian is the founder of Epiveris, bringing over a decade of experience spanning epidemiology, data science, pharmacovigilance, drug safety, and medical device research. Her career includes roles at leading organizations such as Amgen, Sanofi, Regeneron, Johnson & Johnson, and consulting engagements for Roche and Sarepta, alongside academic work at Harvard School of Public Health and the University of Pittsburgh.

Sonja specializes in building predictive analytics platforms for pharma and biotech companies in market access and observational research. She has extensive experience navigating complex global regulatory frameworks including FDA, EMA, and MHRA standards.